About
Management
Joshua Smith
CEO/President
20+ years leading highly innovative business with a clear vision and operational excellence. 8+ years of international regulatory experience and strategic development.
Science Team
Sally duPre, PhD
Senior Research Scientist–
40+ years in biological research and development. Specializing in immune modulators & biochemistry.
Advisors
Mark Hinds
Chairman - Business Development
Executive Chairman of multiple venture funds investing in hyper innovative and disruptive businesses. Mr. Hinds brings connections and 30+ years of business development experience to Immunacor.
Beth McDougall
Chief Medical Officer
20+ years of clinical practice specializing in rare viral health conditions, immunology and degenerative health. Dr Mcdougall leads Immunacor's pioneering development strategies.
David Franco, CFO
Chief Financial Officer
25+ years as a CPA and CFO for rapid growth companies specializing in the medical industry.
Kim Arnott
Lab Manager
30+ years as lab director for top tier hospitals, extensive experience with regulatory compliance and lab operations.
Roland Vandemeer
Advisory Board
30+ years early venture capital experience. Managed $2 billion+.
Kenneth Hunter, PhD
Scientific Advisor
Emeritus Professor of Immunology & Head of applied research. Expert in Immune modulation, 60+ published papers.